FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783703747> ?p ?o ?g. }

• W2783703747 endingPage "736" @default.
• W2783703747 startingPage "727" @default.
• W2783703747 abstract "The aetiology of gout is closely linked to the deposition of monosodium uric acid (MSU) crystals and the consequent activation of the NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome. In this study, we investigated whether oral administration of an NLRP3 inhibitor would be effective to attenuate the symptoms of gout. The effects of oral administration with sulforaphane (SFN) were examined in two mouse models of acute gout induced by injection of MSU crystals into footpads or air pouch. The production of caspase-1 (p10) and IL-1β was examined by immunoblotting and ELISA as hallmarks of NLRP3 inflammasome activation. Oral administration of SFN attenuated MSU crystal-induced swelling and neutrophil recruitment in a mouse foot acute gout model, correlating with the suppression of the NLRP3 inflammasome activation in foot tissues. Consistently, oral administration of SFN blocked MSU-crystal-induced activation of the NLRP3 inflammasome in a mouse air pouch gout model. SFN suppressed NLRP3 inflammasome activation induced by MSU crystals, adenosine triphosphate and nigericin but not by poly(dA:dT) in primary mouse macrophages, independent of the reactive oxygen species pathway. SFN inhibited ligand-independent activation of the NLRP3 inflammasome, suggesting that SFN may act directly on the NLRP3 inflammasome complex. Oral administration of SFN effectively alleviated acute gouty inflammation by suppression of the NLRP3 inflammasome. Our results provide a novel strategy in which oral treatment with SFN may be beneficial in preventing acute attacks of gout." @default.
• W2783703747 created "2018-01-26" @default.
• W2783703747 creator A5008783892 @default.
• W2783703747 creator A5017319680 @default.
• W2783703747 creator A5024664049 @default.
• W2783703747 creator A5048899607 @default.
• W2783703747 creator A5083524882 @default.
• W2783703747 creator A5091417501 @default.
• W2783703747 date "2018-01-10" @default.
• W2783703747 modified "2023-10-17" @default.
• W2783703747 title "Suppression of NLRP3 inflammasome by oral treatment with sulforaphane alleviates acute gouty inflammation" @default.
• W2783703747 cites W1593760300 @default.
• W2783703747 cites W1642748179 @default.
• W2783703747 cites W1664996601 @default.
• W2783703747 cites W1775232482 @default.
• W2783703747 cites W1874333181 @default.
• W2783703747 cites W1973007396 @default.
• W2783703747 cites W1981171441 @default.
• W2783703747 cites W1987339529 @default.
• W2783703747 cites W1991892529 @default.
• W2783703747 cites W1995744610 @default.
• W2783703747 cites W2009800174 @default.
• W2783703747 cites W2018607502 @default.
• W2783703747 cites W2020996714 @default.
• W2783703747 cites W2042816890 @default.
• W2783703747 cites W2049309853 @default.
• W2783703747 cites W2050259192 @default.
• W2783703747 cites W2050449334 @default.
• W2783703747 cites W2075505106 @default.
• W2783703747 cites W2086406618 @default.
• W2783703747 cites W2096317294 @default.
• W2783703747 cites W2120815988 @default.
• W2783703747 cites W2121560754 @default.
• W2783703747 cites W2125297232 @default.
• W2783703747 cites W2126384811 @default.
• W2783703747 cites W2127375495 @default.
• W2783703747 cites W2342364845 @default.
• W2783703747 cites W2413082478 @default.
• W2783703747 cites W2468346663 @default.
• W2783703747 cites W2559896730 @default.
• W2783703747 cites W2572524540 @default.
• W2783703747 doi "https://doi.org/10.1093/rheumatology/kex499" @default.
• W2783703747 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29340626" @default.
• W2783703747 hasPublicationYear "2018" @default.
• W2783703747 type Work @default.
• W2783703747 sameAs 2783703747 @default.
• W2783703747 citedByCount "49" @default.
• W2783703747 countsByYear W27837037472018 @default.
• W2783703747 countsByYear W27837037472019 @default.
• W2783703747 countsByYear W27837037472020 @default.
• W2783703747 countsByYear W27837037472021 @default.
• W2783703747 countsByYear W27837037472022 @default.
• W2783703747 countsByYear W27837037472023 @default.
• W2783703747 crossrefType "journal-article" @default.
• W2783703747 hasAuthorship W2783703747A5008783892 @default.
• W2783703747 hasAuthorship W2783703747A5017319680 @default.
• W2783703747 hasAuthorship W2783703747A5024664049 @default.
• W2783703747 hasAuthorship W2783703747A5048899607 @default.
• W2783703747 hasAuthorship W2783703747A5083524882 @default.
• W2783703747 hasAuthorship W2783703747A5091417501 @default.
• W2783703747 hasBestOaLocation W27837037471 @default.
• W2783703747 hasConcept C126322002 @default.
• W2783703747 hasConcept C139174496 @default.
• W2783703747 hasConcept C162157009 @default.
• W2783703747 hasConcept C164027704 @default.
• W2783703747 hasConcept C185592680 @default.
• W2783703747 hasConcept C187831198 @default.
• W2783703747 hasConcept C203014093 @default.
• W2783703747 hasConcept C2776914184 @default.
• W2783703747 hasConcept C2777056448 @default.
• W2783703747 hasConcept C2777209026 @default.
• W2783703747 hasConcept C2779881121 @default.
• W2783703747 hasConcept C2780402116 @default.
• W2783703747 hasConcept C2780841255 @default.
• W2783703747 hasConcept C48349386 @default.
• W2783703747 hasConcept C502942594 @default.
• W2783703747 hasConcept C55493867 @default.
• W2783703747 hasConcept C71924100 @default.
• W2783703747 hasConcept C98274493 @default.
• W2783703747 hasConceptScore W2783703747C126322002 @default.
• W2783703747 hasConceptScore W2783703747C139174496 @default.
• W2783703747 hasConceptScore W2783703747C162157009 @default.
• W2783703747 hasConceptScore W2783703747C164027704 @default.
• W2783703747 hasConceptScore W2783703747C185592680 @default.
• W2783703747 hasConceptScore W2783703747C187831198 @default.
• W2783703747 hasConceptScore W2783703747C203014093 @default.
• W2783703747 hasConceptScore W2783703747C2776914184 @default.
• W2783703747 hasConceptScore W2783703747C2777056448 @default.
• W2783703747 hasConceptScore W2783703747C2777209026 @default.
• W2783703747 hasConceptScore W2783703747C2779881121 @default.
• W2783703747 hasConceptScore W2783703747C2780402116 @default.
• W2783703747 hasConceptScore W2783703747C2780841255 @default.
• W2783703747 hasConceptScore W2783703747C48349386 @default.
• W2783703747 hasConceptScore W2783703747C502942594 @default.
• W2783703747 hasConceptScore W2783703747C55493867 @default.
• W2783703747 hasConceptScore W2783703747C71924100 @default.
• W2783703747 hasConceptScore W2783703747C98274493 @default.
• W2783703747 hasFunder F4320309788 @default.

• next